Novo Nordisk A/S 2011 AR2
The report highlights Novo Nordisk's financial, social, and environmental performance for the fiscal year 2011. The company achieved strong financial results with sales increasing by 9% to DKK 66,346 million, driven by modern insulins and Victoza. In social performance, Novo Nordisk expanded access to care, training approximately 835,000 healthcare professionals and reaching an estimated 24 million patients with its injectable diabetes products. Environmentally, the company exceeded its long-term targets, reducing energy consumption by 21% and water consumption by 34% compared to the 2007 baseline, while also decreasing CO2 emissions from energy consumption by 56% compared to the 2004 baseline.
Company: Novo Nordisk A/S
Sector: Manufacturing
Country: Denmark
Year: 2011
Type: AR2
Pages: 116
Novo Nordisk A/S
The report highlights Novo Nordisk's financial, social, and environmental performance for the fiscal year 2011. The company achieved strong financial results with sales increasing by 9% to DKK 66,346 million, driven by modern insulins and Victoza. In social performance, Novo Nordisk expanded access to care, training approximately 835,000 healthcare professionals and reaching an estimated 24 million patients with its injectable diabetes products. Environmentally, the company exceeded its long-term targets, reducing energy consumption by 21% and water consumption by 34% compared to the 2007 baseline, while also decreasing CO2 emissions from energy consumption by 56% compared to the 2004 baseline.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2011
Reporting Period
Jan 1, 2011 - Dec 31, 2011
Fiscal Year
2011
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees